As of 2025-07-07, the EV/EBITDA ratio of Erytech Pharma SA (ERYP.PA) is 0.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ERYP.PA's latest enterprise value is -11.85 mil EUR. ERYP.PA's TTM EBITDA according to its financial statements is -23.57 mil EUR. Dividing these 2 quantities gives us the above ERYP.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 10.6x | 8.9x |
| Forward P/E multiples | 10.7x - 12.0x | 11.8x |
| Fair Price | (8.49) - (8.42) | (8.16) |
| Upside | -1801.1% - -1787.0% | -1735.8% |
| Date | EV/EBITDA |